Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bolliger

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Annals of Neurology|September 10, 2025
Cuneiform Nucleus Stimulation Can Assist Gait Training to Promote Locomotor Recovery in Individuals With Incomplete TetraplegiaAnna-Sophie Hofer, Lennart H Stieglitz, Marc Bolliger, et al.
Nature Communications|May 12, 2026
Anti-Nogo-A NG101 treatment induces changes in spinal cord micro- and macrostructure following spinal cord injuryLynn Farner, Paulina S Scheuren, Kiomars Sharifi, et al.
Spinal Cord|April 28, 2018
Lower extremity outcome measures: considerations for clinical trials in spinal cord injuryMarc Bolliger, Andrew R Blight, Edelle C Field-Fote, et al.
The Lancet. Neurology|December 20, 2024
Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trialNorbert Weidner, Rainer Abel, Doris Maier, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Annals of Neurology|September 10, 2025
Cuneiform Nucleus Stimulation Can Assist Gait Training to Promote Locomotor Recovery in Individuals With Incomplete TetraplegiaAnna-Sophie Hofer, Lennart H Stieglitz, Marc Bolliger, et al.
Nature Communications|May 12, 2026
Anti-Nogo-A NG101 treatment induces changes in spinal cord micro- and macrostructure following spinal cord injuryLynn Farner, Paulina S Scheuren, Kiomars Sharifi, et al.
Spinal Cord|April 28, 2018
Lower extremity outcome measures: considerations for clinical trials in spinal cord injuryMarc Bolliger, Andrew R Blight, Edelle C Field-Fote, et al.
The Lancet. Neurology|December 20, 2024
Safety and efficacy of intrathecal antibodies to Nogo-A in patients with acute cervical spinal cord injury: a randomised, double-blind, multicentre, placebo-controlled, phase 2b trialNorbert Weidner, Rainer Abel, Doris Maier, et al.
Pageof 6